Gosselin E J, Brown M F, Anderson C L, Zipf T F, Guyre P M
Department of Physiology, Dartmouth Medical School, Hanover, NH 03756.
J Immunol. 1990 Mar 1;144(5):1817-22.
Human FcR for IgG can be divided into three classes (Fc gamma RI, II, and III) based on their structure and reactivity with mAb. Fc gamma RII can be further subdivided into two categories based on functional and biochemical assays. These two Fc gamma RII subtypes were initially recognized by the failure of T cells from 40% of individuals to proliferate in response to mAb Leu 4 (mouse IgG1, anti-CD3), a response that requires the binding of the Fc region of the Leu 4 mAb to Fc gamma RII on monocyte accessory cells. Inas-much as mouse IgG1, does not bind efficiently to the nonresponder form of Fc gamma RII, mAb Leu 4 is unable to induce proliferation in these individuals. IEF data on Fc gamma RII from Leu 4 responder and nonresponder individuals suggested that the structural gene for Fc gamma RII consisted of two allelic forms R (responder) and N (nonresponder) producing the phenotypes RR, RN, and NN. Thus, exclusive expression of the nonresponder allele in monocytes of "nonresponder" individuals, appeared to be responsible for the lack of proliferation observed. In cooperation with the IVth International Conference on Human Leukocyte Differentiation Antigens, we analyzed CDw32 mAb to determine if they could distinguish the responder and nonresponder forms of Fc gamma RII. We report that mAb 41H16 binds preferentially to the responder allotypic form of Fc gamma RII expressed on human monocytes. When quantitative flow cytometry is used to measure the binding of both mAb 41H16 (responder Fc gamma RII) and mAb IV.3 (all myeloid cell Fc gamma RII), we are able to subdivide the responder population into homozygous and heterozygous responders. In addition, mAb 41H16 blocks the binding of mAb IV.3 to monocytes and inhibits proliferation when added to cells before addition of mAb Leu 4. We also show that polymorphonuclear leukocytes and platelets have the same allotypic differences in the binding of 41H16 as do monocytes. However, a subset of lymphocytes (previously shown to be B cells) expresses the 41H16 epitope with no evidence for donor to donor variability.
人类IgG的Fc受体可根据其结构及与单克隆抗体的反应性分为三类(FcγRI、II和III)。基于功能和生化分析,FcγRII可进一步细分为两类。这两种FcγRII亚型最初是通过40%个体的T细胞对单克隆抗体Leu 4(小鼠IgG1,抗CD3)无增殖反应而被识别的,该反应需要Leu 4单克隆抗体的Fc区域与单核细胞辅助细胞上的FcγRII结合。由于小鼠IgG1不能有效地与FcγRII的无反应形式结合,Leu 4单克隆抗体无法在这些个体中诱导增殖。来自Leu 4反应者和无反应者个体的FcγRII的IEF数据表明,FcγRII的结构基因由两种等位基因形式R(反应者)和N(无反应者)组成,产生RR、RN和NN表型。因此,“无反应者”个体单核细胞中无反应者等位基因的排他性表达似乎是观察到的增殖缺乏的原因。与第四届人类白细胞分化抗原国际会议合作,我们分析了CDw32单克隆抗体,以确定它们是否能区分FcγRII的反应者和无反应者形式。我们报告单克隆抗体41H16优先结合在人类单核细胞上表达的FcγRII的反应者同种异型形式。当使用定量流式细胞术测量单克隆抗体41H16(反应者FcγRII)和单克隆抗体IV.3(所有髓样细胞FcγRII)的结合时,我们能够将反应者群体细分为纯合反应者和杂合反应者。此外,单克隆抗体41H16可阻断单克隆抗体IV.3与单核细胞的结合,并在加入单克隆抗体Leu 4之前加入细胞时抑制增殖。我们还表明,多形核白细胞和血小板在41H16结合方面具有与单核细胞相同的同种异型差异。然而,一部分淋巴细胞(先前显示为B细胞)表达41H16表位,没有供体间变异性的证据。